These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 24955523)

  • 1. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward organometallic antischistosomal drug candidates.
    Hess J; Keiser J; Gasser G
    Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
    Xiao SH; Sun J; Chen MG
    Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 12. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
    Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
    Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
    [No Abstract]   [Full Text] [Related]  

  • 15. Praziquantel.
    Cioli D; Pica-Mattoccia L
    Parasitol Res; 2003 Jun; 90 Supp 1():S3-9. PubMed ID: 12811543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
    Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
    ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
    da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
    SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility or resistance of praziquantel in human schistosomiasis: a review.
    Wang W; Wang L; Liang YS
    Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.